Provided by Tiger Fintech (Singapore) Pte. Ltd.

Viking Therapeutics

33.40
+1.304.05%
Post-market: 30.65-2.7500-8.23%19:59 EDT
Volume:5.90M
Turnover:197.66M
Market Cap:3.75B
PE:-28.96
High:34.40
Open:32.65
Low:32.16
Close:32.10
Loading ...

BUZZ-Eli Lilly jumps as pill leads to 7.9% weight loss in late-stage trial

Reuters
·
17 Apr

Eli Lilly's stock soars as successful trial of weight-loss pill is a game changer

Dow Jones
·
17 Apr

Viking Therapeutics to Report Financial Results for First Quarter 2025 on April 23, 2025

PR Newswire
·
17 Apr

Eli Lilly Stock Down 8.2% in a Month: Should You Buy the Dip?

Zacks
·
16 Apr

Viking Therapeutics’ VK2735: A Promising Contender Amidst Pfizer’s Setback

TIPRANKS
·
16 Apr

Promising Pipeline and Strategic Developments Drive Buy Rating for Viking Therapeutics

TIPRANKS
·
16 Apr

Pfizer Halts Obesity Pill Development Amid Safety Concerns

Zacks
·
16 Apr

NVO, LLY, GPCR & VKTX Stocks Gain Following PFE's Obesity Study Setback

Zacks
·
15 Apr

Viking Therapeutics’ VK2735 Gains Buy Rating Amid Pfizer’s GLP-1 Drug Halt and Promising Trial Results

TIPRANKS
·
15 Apr

Pfizer's $130B Weight-Loss Dream Just Collapsed

GuruFocus.com
·
14 Apr

BTIG highlights some reasons to own Viking shares after danuglipron discontinued

TIPRANKS
·
14 Apr

Pfizer just had a big setback in its race for an Ozempic competitor

Quartz
·
14 Apr

Smaller obesity drugmakers jump after Pfizer scraps weight-loss pill

TIPRANKS
·
14 Apr

Viking Seen as Potential Ticket To Get Pfizer Back Into Obesity Game -- Market Talk

Dow Jones
·
14 Apr

US STOCKS-Tech stocks power Wall St higher after Trump's tariff relief for some electronics

Reuters
·
14 Apr

Viking, Structure rally after Pfizer halts obesity drug development

TIPRANKS
·
14 Apr

Obesity Drugmakers Shares Rise After Pfizer Ends Development of Weight-Loss Pill Danuglipron

Reuters
·
14 Apr

BUZZ-U.S. STOCKS ON THE MOVE-Goldman Sachs, Pfizer, Best Buy

Reuters
·
14 Apr

BUZZ-Obesity drugmakers rise after Pfizer ends development of weight-loss pill

Reuters
·
14 Apr

Will Viking Therapeutics Be a Top Healthcare Stock in 10 Years?

Motley Fool
·
10 Apr